Gigantol protects retinal pigment epithelial cells against high glucose-induced apoptosis, oxidative stress and inflammation by inhibiting MTDH-mediated NF-kB signaling pathway

References

• Li W, Xiao H. Dihydromyricetin alleviates high glucose-induced oxidative stress and apoptosis in human retinal pigment epithelial cells by downregulating miR-34a expression. Diabetes Metab Syndr Obes. 2021;14:387–397.
   PubMed Web of Science ®Google Scholar
• Bourne RRA, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1(6):e339-49.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801–1815.
   PubMed Web of Science ®Google Scholar
• Yau JWY, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564.
   PubMed Web of Science ®Google Scholar
• Zapadka TE, Lindstrom S, Batoki JC, et al. Aryl hydrocarbon receptor agonist VAF347 impedes retinal pathogenesis in diabetic mice. Int J Mol Sci. 2021;22(9):4335.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang J, Chen L. The cells involved in the pathological process of diabetic retinopathy. Biomed Pharmacother. 2020;132:110818.
   PubMed Web of Science ®Google Scholar
• Hatano M, Tokuda K, Kobayashi Y, et al. Inhibitory effect of nintedanib on VEGF secretion in retinal pigment epithelial cells induced by exposure to a necrotic cell lysate. PLoS One. 2019;14(8):e0218632.
   PubMed Web of Science ®Google Scholar
• Luo R, Jin H, Li L, et al. Long noncoding RNA MEG3 inhibits apoptosis of retinal pigment epithelium cells induced by high glucose via the miR-93/Nrf2 axis. Am J Pathol. 2020;190(9):1813–1822.
   PubMed Web of Science ®Google Scholar
• Feng L, Liang L, Zhang S, et al. HMGB1 downregulation in retinal pigment epithelial cells protects against diabetic retinopathy through the autophagy-lysosome pathway. Autophagy. 2022;18(2):320–339.
   PubMed Web of Science ®Google Scholar
• Tosi GM, Giustarini D, Franci L, et al. Superior properties of N-acetylcysteine ethyl ester over N-acetyl cysteine to prevent retinal pigment epithelial cells oxidative damage. Int J Mol Sci. 2021;22(2):600.
   Web of Science ®Google Scholar
• Willermain F, Scifo L, Weber C, et al. Potential interplay between hyperosmolarity and inflammation on retinal pigmented epithelium in pathogenesis of diabetic retinopathy. Int J Mol Sci. 2018;19(4):1056.
   PubMed Web of Science ®Google Scholar
• Tababat-Khani P, Berglund LM, Agardh C-D, et al. Photocoagulation of human retinal pigment epithelial cells in vitro: evaluation of necrosis, apoptosis, cell migration, cell proliferation and expression of tissue repairing and cytoprotective genes. PLoS One. 2013;8(8):e70465.
   PubMed Web of Science ®Google Scholar
• Luo Y, Dong X, Lu S, et al. Gypenoside XVII alleviates early diabetic retinopathy by regulating Muller cell apoptosis and autophagy in db/db mice. Eur J Pharmacol. 2021;895:173893.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu M, Fei B, et al. Identification of natural compound derivative for inhibition of XLF and overcoming chemoresistance in colorectal cancer cells. Drug Des Devel Ther. 2019;13:3823–3834.
   PubMed Web of Science ®Google Scholar
• Xue Y, Deng Q, Zhang Q, et al. Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway. Sci Rep. 2020;10(1):22265.
   PubMed Web of Science ®Google Scholar
• Chen H, Huang Y, Huang D, et al. Protective effect of gigantol against hydrogen peroxideinduced apoptosis in rat bone marrow mesenchymal stem cells through the PI3K/Akt pathway. Mol Med Rep. 2018;17(2):3267–3273.
   PubMed Web of Science ®Google Scholar
• Xue Y-R, Yao S, Liu Q, et al. Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver. Acta Pharmacol Sin. 2020;41(11):1433–1445.
   PubMed Web of Science ®Google Scholar
• Chen MF, Liou S-S, Hong T-Y, et al. Gigantol has protective effects against high Glucose-Evoked nephrotoxicity in mouse glomerulus mesangial cells by suppressing ROS/MAPK/NF-kappaB signaling pathways. Molecules. 2018;24(1):80.
   Web of Science ®Google Scholar
• Yang Y, Yang Q, Yu J, et al. Characterization of structural requirement for binding of gigantol and aldose reductase. Front Biosci (Landmark Ed). 2019;24(6):1024–1036.
   PubMedGoogle Scholar
• Su Z-Z, Kang D-C, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 2002;21(22):3592–3602.
   PubMed Web of Science ®Google Scholar
• Sultan A, Sahar N-E, Riaz SK, et al. Metadherin (MTDH) overexpression significantly correlates with advanced tumor grade and stages among colorectal cancer patients. Mol Biol Rep. 2021;48(12):7999–8007.
   PubMed Web of Science ®Google Scholar
• Jin H, Wu Z, Tan B, et al. CircITGA7 suppresses gastric cancer progression through miR-1471/MTDH axis. Front Cell Dev Biol. 2021;9:688970.
   PubMed Web of Science ®Google Scholar
• Li P-P, Li R-G, Huang Y-Q, et al. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability. Aging (Albany NY). 2021;13(21):24171–24191.
   PubMedGoogle Scholar
• Noch EK, Khalili K. The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease. Adv Cancer Res. 2013;120:159–192.
   PubMed Web of Science ®Google Scholar
• Emdad L, et al. AEG-1/MTDH/LYRIC: a promiscuous protein partner critical in cancer, obesity, and CNS diseases. Adv Cancer Res. 2016;131:97–132.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang N, Han D, et al. MTDH promotes intestinal inflammation by positively regulating TLR signalling. J Crohns Colitis. 2021;15(12):2103–2117.
   PubMed Web of Science ®Google Scholar
• Liu W-T, Peng F-F, Li H-Y, et al. Metadherin facilitates podocyte apoptosis in diabetic nephropathy. Cell Death Dis. 2016;7(11):e2477.
   PubMedGoogle Scholar
• Liu W, Chen X, Wang Y, et al. Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice. Pharmacol Res. 2019;150:104506.
   PubMed Web of Science ®Google Scholar
• You J, Qi S, Du Y, et al. Multiple bioinformatics analyses of integrated gene expression profiling data and verification of hub genes associated with diabetic retinopathy. Med Sci Monit. 2020;26:e923146.
   PubMed Web of Science ®Google Scholar
• Li W, Shen X, Wang Y, et al. The effect of Shengpuhuang-tang on retinal inflammation in streptozotocin-induced diabetic rats by NF-kappaB pathway. J Ethnopharmacol. 2020;247:112275.
   PubMed Web of Science ®Google Scholar
• Won J-H, Kim J-Y, Yun K-J, et al. Gigantol isolated from the whole plants of Cymbidium goeringii inhibits the LPS-induced iNOS and COX-2 expression via NF-kappaB inactivation in RAW 264.7 macrophages cells. Planta Med. 2006;72(13):1181–1187.
   PubMed Web of Science ®Google Scholar
• Rong C, Shi Y, Huang J, et al. The effect of metadherin on NF-kappaB activation and downstream genes in ovarian cancer. Cell Transplant. 2020;29:963689720905506.
   PubMed Web of Science ®Google Scholar
• Nawaz IM, Rezzola S, Cancarini A, et al. Human vitreous in proliferative diabetic retinopathy: characterization and translational implications. Prog Retin Eye Res. 2019;72:100756.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhou Z, Zhang B, et al. Efficacy and safety of various treatments for proliferative diabetic retinopathy: a systematic review and network meta-analysis. Front Pharmacol. 2021;12:709501.
   PubMed Web of Science ®Google Scholar
• Lim G, Bellerno V, Xie Y, et al. Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review. Eye Vis (Lond). 2020;7:21.
   PubMedGoogle Scholar
• Silva PS, Cavallerano JD, Sun JK, et al. Effect of systemic medications on onset and progression of diabetic retinopathy. Nat Rev Endocrinol. 2010;6(9):494–508.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Liu J, Bi C, et al. Knockdown of FOXO6 inhibits high glucose-induced oxidative stress and apoptosis in retinal pigment epithelial cells. J Cell Biochem. 2019;120(6):9716–9723.
   PubMed Web of Science ®Google Scholar
• Zhou H, Xu Q, Li H, et al. Proteomics identifies new potential therapeutic targets of diabetic retinopathy. Bioengineered. 2022;13(4):9916–9927.
   PubMed Web of Science ®Google Scholar
• Fang H, Hu X, Wang M, et al. Anti-osmotic and antioxidant activities of gigantol from Dendrobium aurantiacum var. denneanum against cataractogenesis in galactosemic rats. J Ethnopharmacol. 2015;172:238–246.
   PubMed Web of Science ®Google Scholar
• Huang HW, Yang CM, Yang CH. Fibroblast growth factor type 1 ameliorates high-glucose-induced oxidative stress and neuroinflammation in retinal pigment epithelial cells and a streptozotocin-induced diabetic rat model. Int J Mol Sci. 2021;22(13):7233.
   Web of Science ®Google Scholar
• El-Ashmawy NE, El-Zamarany EA, Khedr EG, et al. Activation of EMT in colorectal cancer by MTDH/NF-kappaB p65 pathway. Mol Cell Biochem. 2019;457(1-2):83–91.
   PubMed Web of Science ®Google Scholar
• Duan X, Song Y, Li F, et al. Metadherin silencing results in the inhibition of pyroptosis in lipopolysaccharide/adenosine triphosphate – stimulated renal tubular epithelial cells. Tissue Cell. 2022;76:101790.
   PubMed Web of Science ®Google Scholar